A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.
Stage-specific immunity (to the sporozoite, the asexual blood-stages and the sexual stages of malaria) has been well documented and antigens from each stage are being tested for their potential as vaccine candidates. Recently it has become clear that the liver stage can also be the target of protective immune responses; however, only the circumsporozoite protein has been identified as a protective liver antigen. It is critical for vaccine evaluation and development to identify other liver antigens and assess their potential role in immunity. In this paper we describe a monoclonal antibody, which recognizes a liver-specific antigen of Plasmodium berghei (referred to as Pbl1). Passive immunization studies using this antibody suggest that it may influence the course of sporozoite-induced infections.
Winger
L
L
Department of Pure and Applied Biology, Imperial College, London, England.
Suhrbier
A
A
O'Dowd
C A
CA
Hodivala
K J
KJ
Sinden
R E
RE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D000953:Antigens, Protozoan / Q000302:isolation & purification*; D007116:Immunization, Passive; D051379:Mice; D008807:Mice, Inbred BALB C; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000953:Antigens, Protozoan